Dominick Colangelo

Insider Reports History

Location
Waltham, MA
Signature
/s/ Christopher Galletta, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dominick Colangelo:

Company Role Class Num Shares Value Price $ Report Date Ownership
Vericel Corp President and CEO, Director Common Stock 260,354 $10,812,501 $41.53 15 May 2025 Direct
Vericel Corp President and CEO, Director Restricted Stock Unit 54,750 $2,850,833 $52.07 24 Feb 2025 Direct
Trevi Therapeutics, Inc. Director Nonstatutory Stock Option (right to buy) 45,000 11 Jun 2025 Direct
Vericel Corp President and CEO, Director Stock Option (Right to Buy) 0 15 May 2025 Direct

Insider Reports Filed by Dominick Colangelo

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TRVI Trevi Therapeutics, Inc. 11 Jun 2025 1 $0 4 Director 13 Jun 2025, 16:00
VCEL Vericel Corp 14 May 2025 6 $-1,103,625 4 President and CEO, Director 16 May 2025, 16:06
VCEL Vericel Corp 09 Apr 2025 6 $-1,925,875 4 President and CEO, Director 11 Apr 2025, 16:05
VCEL Vericel Corp 12 Mar 2025 6 $-2,345,104 4 President and CEO, Director 14 Mar 2025, 16:07
VCEL Vericel Corp 24 Feb 2025 3 $-442,659 4 President and CEO, Director 26 Feb 2025, 16:05
VCEL Vericel Corp 20 Feb 2025 2 $0 4 President and CEO, Director 24 Feb 2025, 16:05
VCEL Vericel Corp 18 Feb 2025 8 $-553,074 4 President and CEO, Director 20 Feb 2025, 16:05
VCEL Vericel Corp 13 Nov 2024 6 $-1,810,550 4 President and CEO, Director 15 Nov 2024, 16:05
VCEL Vericel Corp 16 Oct 2024 6 $-1,324,400 4 President and CEO, Director 18 Oct 2024, 16:05
VCEL Vericel Corp 11 Sep 2024 6 $-1,421,525 4 President and CEO, Director 13 Sep 2024, 16:05
VCEL Vericel Corp 14 Aug 2024 6 $-1,493,975 4 President and CEO, Director 16 Aug 2024, 16:05
VCEL Vericel Corp 17 Jul 2024 6 $-1,695,925 4 President and CEO, Director 19 Jul 2024, 16:05
TRVI Trevi Therapeutics, Inc. 13 Jun 2024 1 $0 4 Director 14 Jun 2024, 16:30
VCEL Vericel Corp 12 Jun 2024 6 $-1,420,650 4 President and CEO, Director 14 Jun 2024, 16:05
VCEL Vericel Corp 15 May 2024 6 $-1,600,900 4 President and CEO, Director 17 May 2024, 16:05
VCEL Vericel Corp 30 Apr 2024 6 $299,977 4 President and CEO, Director 01 May 2024, 16:05
VCEL Vericel Corp 17 Apr 2024 6 $-1,487,850 4 President and CEO, Director 19 Apr 2024, 16:05
VCEL Vericel Corp 13 Mar 2024 6 $-1,446,375 4 President and CEO, Director 15 Mar 2024, 16:07
VCEL Vericel Corp 22 Feb 2024 2 $0 4 President and CEO, Director 26 Feb 2024, 16:05
VCEL Vericel Corp 20 Feb 2024 9 $-892,238 4 President and CEO, Director 22 Feb 2024, 16:06
VCEL Vericel Corp 14 Feb 2024 6 $-1,571,500 4 President and CEO, Director 16 Feb 2024, 16:05
VCEL Vericel Corp 12 Feb 2024 3 $-164,879 4 President and CEO, Director 13 Feb 2024, 16:05
VCEL Vericel Corp 17 Jan 2024 6 $-1,179,350 4 President and CEO, Director 19 Jan 2024, 16:06
VCEL Vericel Corp 13 Dec 2023 7 $-768,120 4 President and CEO, Director 15 Dec 2023, 16:05
VCEL Vericel Corp 06 Dec 2023 6 $-745,811 4 President and CEO, Director 08 Dec 2023, 16:05
TRVI Trevi Therapeutics, Inc. 28 Jun 2023 1 $0 4 Director 30 Jun 2023, 16:00
VCEL Vericel Corp 17 Feb 2023 9 $-285,258 4 President and CEO, Director 22 Feb 2023, 19:48
VCEL Vericel Corp 11 Feb 2023 3 $-102,990 4 President and CEO, Director 14 Feb 2023, 15:04
VCEL Vericel Corp 06 Feb 2023 3 $-99,542 4 President and CEO, Director 08 Feb 2023, 15:01
VCEL Vericel Corp 10 Jan 2023 3 $-53,197 4 President and CEO, Director 12 Jan 2023, 15:11
TRVI Trevi Therapeutics, Inc. 23 Jun 2022 1 $0 4/A Director 01 Jul 2022, 16:54
VCEL Vericel Corp 18 Feb 2022 6 $-447,139 4 President and CEO, Director 22 Feb 2022, 15:07
VCEL Vericel Corp 11 Feb 2022 3 $-379,080 4 President and CEO, Director 15 Feb 2022, 15:48
VCEL Vericel Corp 06 Feb 2022 3 $-338,625 4 President and CEO, Director 08 Feb 2022, 16:01
TRVI Trevi Therapeutics, Inc. 16 Jun 2021 1 $0 4 Director 17 Jun 2021, 16:00